Taiwan – Safety Assessment for Novel Food Ingredients

    On January 27, 2026, the Taiwan Food and Drug Administration (TFDA) published the “Principles for Safety Assessment of Novel Food Ingredients.”       These Principles, which will apply to Novel Food ingredients in Taiwan, describe the application process and the essential requirements to consider:          1. Definition of a […]

China Selects First Batch of New Cosmetic Ingredients for Innovation Guidance

In October, the China National Institutes for Food and Drug Control (NIFDC) released the first batch of new cosmetic ingredients (NCIs) selected under its innovation guidance program. This initiative marks a key step in China’s strategy to encourage innovation and self-reliance in the cosmetics sector by promoting the research, development, and application of novel ingredients. […]

Europe: Updated list of permitted substances in Denmark + Update on EU Maximum Permitted Levels

  Denmark: Update of the National Positive List of Substances Permitted in Foods and Food Supplements     Early in December, Danish authorities published an updated list of substances, other than vitamins and minerals, that are permitted in Foods, including Food Supplements.     This update, detailed in BEK 1522, replaces the previous BEK 616 published […]

Europe: Maximum Levels for Mineral Oil Hydrocarbons in Food Supplements

      Maximum Levels for Mineral Oil Hydrocarbons in Food Supplements     The European Commission (EC) is working on measures to establish maximum levels and control requirements for Mineral Oil Hydrocarbons (MOHs) on food, specifically on Mineral Oil Aromatic Hydrocarbons (MOAH) and Mineral Oil Saturated Hydrocarbons (MOSH).       These actions will […]

Belgium: Draft Royal Decree for Manufacturing and Trading Foodstuffs with Plants

    Draft Royal Decree to Amend Legislation on Manufacturing and Trading Foodstuffs with Plants or Plant Preparations Submitted     On July 1st, the Belgian authorities submitted a new TRIS notification regarding a draft Royal Decree that amends the existing legislation on the manufacture and trade of foodstuffs containing plants or plant preparations.   […]

Europe – DMAE and D-chiro-inositol vs Novel Food Classification

      DMAE and D-chiro-inositol versus Novel Food Classification • DMAE     DMAE (Dimethylaminoethanol / Dimethylaminoethanol bitartrate) has recently been categorized as an unauthorized Novel Food in the EU Novel Food Catalogue. However, this ingredient is already present in many products currently available in the EU market.     We have been informed […]

Brazil: Public Consultation on Ingredient Specs | Ban on Food Supplements with ora-pro-nobis | Safe Use of Erythrosine | Update on Plastic Packaging

    Brazil and New Normative of Specifications for Ingredients     From May 2nd until June 16th, a public consultation is being held regarding ANVISA’s proposal for a new norm that outlines the specifications for ingredients. This proposal is structured into 4 annexes:         • Annex 1 – New Ingredients with […]

USA: Tariff-Exempt Dietary Ingredients | FDA Opinion on New Dietary Ingredients | FDA & the Potential Halt of GRAS Process | Restriction on the Sale of Dietary Supplements to Children and Adolescents

      Dietary Ingredients Exempt from Global and Reciprocal Tariffs Although some Global or Reciprocal Tariffs may be suspended for 90 days, certain Dietary Supplement ingredients have been declared exempt. According to Annex II of the executive order that implemented these tariffs, the following dietary ingredients are exempt: Vitamin A Vitamins B1, B2, B5, […]

Brazil: New normative of specifications for ingredients (new ingredients and novel foods)

Last week, Brazil approved a new Normative Instruction that will regulate petitions in the food sector based on approvals already granted by Equivalent Authorities from Foreign Countries (known as Autoridades Reguladores Estrangeiras Equivalentes – AREEs – in Portuguese). This new norm is a significant step toward streamlining Brazil’s approval system, as it will allow petitions submitted to ANVISA to reference […]